Form 4: ScanSource CEO Michael Baur Executes Stock Transactions Under 10b5-1 Plan
SEC Form 4 Filing
ScanSource CEO Michael Baur executed multiple stock option exercises and sales under a pre-arranged 10b5-1 trading plan.
Summary
- Michael Baur, CEO and Chairman of the Board of ScanSource, Inc., engaged in several transactions involving the company's stock.
- On November 19, 2024, Baur exercised options to acquire 21,688 shares at $24.68 per share and then sold the same amount of shares at a weighted average price of $49.12.
- On November 20, 2024, Baur exercised options to acquire 8,312 shares at $24.68 per share and then sold the same amount of shares at a weighted average price of $48.98.
- These transactions were executed under a Rule 10b5-1 sales plan adopted on September 1, 2023.
- Following these transactions, Baur's direct holdings of ScanSource common stock decreased by the number of shares sold, but his holdings of stock options decreased by the number of options exercised.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The transactions are part of a pre-arranged plan, which is a normal practice. However, the sale of shares could be perceived negatively by some investors.
Positives
- The transactions were conducted under a pre-arranged 10b5-1 trading plan, which is a common practice for corporate insiders to avoid accusations of insider trading.
- The exercise of stock options indicates that the CEO is taking advantage of the opportunity to convert options into shares.
Negatives
- The sale of shares by the CEO could be interpreted as a lack of confidence in the company's future performance, although this is mitigated by the pre-arranged nature of the sales plan.
Risks
- The market may react negatively to the CEO selling shares, even if it is part of a pre-arranged plan.
- There is a risk that the market may interpret the sales as a sign of the CEO's lack of confidence in the company's future prospects.
Industry Context
This type of transaction is common for executives of publicly traded companies, especially those with stock-based compensation. The use of a 10b5-1 plan is a standard practice to avoid insider trading concerns.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies, including those in the technology distribution sector like ScanSource.
- Similar transactions are regularly reported by executives at companies like Ingram Micro and Tech Data, which are also major players in the technology distribution industry.
- The exercise and sale of stock options are typical components of executive compensation packages, and the reported prices are within the expected range for such transactions.
Stakeholder Impact
- Shareholders may react to the CEO's stock sales, although the pre-arranged nature of the transactions should mitigate any negative impact.
- Employees may view the CEO's actions as a normal part of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 09/01/2023 | Date the Rule 10b5-1 Sales Plan was adopted by the reporting person. |
| 11/19/2024 | Date of the first set of stock option exercises and sales. |
| 11/20/2024 | Date of the second set of stock option exercises and sales. |
| 11/21/2024 | Date the SEC Form 4 was signed. |
Keywords
ScanSource, Michael Baur, stock options, Rule 10b5-1, insider trading, stock sales, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.